Clinical significance of multiple tumor marker protein chip in monitoring the recurrence, progression and metastasis of lung cancer

Chinese Journal of Lung Cancer

Volumn 10, Issue 4, 2007, Pages 296-300

  Yang, Xueqin ^a   Wang, Dong ^a   Li, Zengpeng ^a   Wang, Ge ^a   Yang, Zhenzhou ^a   Yang, Zhixiang ^a   Yang, Yuqinq ^a   Jiang, Yaoguang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Lung neoplasms; Monitoring; Multiple tumor marker protein chip

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 242 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; METASTASIS; PROTEIN MICROARRAY;

EID: 34548783160     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wang J, Xu F, Zhou QH. Epidemiological advances of lung cancer. Chin J Lung Cancer, 2005,8(5):395-400.
2. von Eggeling F, Davies H, Lomas L, et al. Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research. Biotechniques,2000,29(5):1066-1070.
3. Weinberger SR, Dalmasso EA, Fung ET. Current achievements using ProteinChip Array technology. Curr Opin Chem Biol,2002,6 (1):86-91.
4. Wang J, Wang D, Xiang DB, et al. The clinical significance of C-12 multiple tumor marker protein chip detective system in diagnosis of lung cancer. Med J Chin PLA,2006,31(4):78-79.
5. Hatzakis KD, Froudarakis ME, Bouros D, et al. Prognostic value of serum tumor markers in patients with lung cancer. Respiration, 2002,69(1):25-29.
6. Zuo Q, Zhang JY, Zheng H, et al. Diagnostic value of multiple tumor marker protein biochip detective system for lung cancer. Chin J Lung Cancer,2004,7(2):154-157.
7. Ando S, Kimura H, Iwai N, et al. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer. Anticancer Res,2001, 21(4B):3085-3092.
8. Salgia R, Harpole D, Herndon JE, et al. Role of serum tumor markers CA 125 and CEA in non-small cell lung cancer. Anticancer Res,2001,21(2B):1241-1246.
9. Niklinski J, Furman M. Clinical tumour markers in lung cancer. Eur J Cancer Prev,1995,4(2):129-138.
10. Milman N, Pedersen LM. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer. Oncol Rep,2002,9(1):193-198.
11. Fracchia A, Ubbiali A, El Bitar O, et al. A comparative study on ferritin concentration in serum and bilateral bronchoalveolar lavage fluid of patients with peripheral lung cancer versus control subjects. Oncology,1999,56(3):181- 188.
12. Okunaka T, Kato H, Konaka C, et al. Primary lung cancer produ cing alpha-fetoprotein. Ann Thorac Surg,1992,53(1):151-152.
13. Yamagata T, Yamagata Y, Nakanishi M, et al. A case of primary lung cancer producing alpha-fetoprotein. Can Respir J,2004,11 (7):504-506.